Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
China Journal of Chinese Materia Medica ; (24): 3865-3873, 2023.
Article in Chinese | WPRIM | ID: wpr-981519

ABSTRACT

This study investigated the effect of guarana on plasma lipid metabolites in obese rats and analyzed its mechanism in the treatment of dyslipidemia in obesity. High-fat diet was used to establish obese rat models, and the therapeutic effect of guarana on obese rats was evaluated by measuring body weight, white fat, liver weight, and lipid content, as well as observing liver histomorphology. Lipid metabolites in plasma of rats in each group were detected by UHPLC-Q-TOF-MS lipidomics. The protein expressions of fatty acid synthase, acetyl-CoA carboxylase 1, triglyceride synthesis enzyme, carnitine palmitoyltransferase Ⅰ, and acetyl-coenzyme A acyltransferase 2 in rat liver were detected using Western blot. The results revealed that guarana significantly reduced body weight, white fat, and liver weight of obese rats due to high-fat diet, and alleviated dyslipidemia and liver steatosis. Lipidomics showed that some triglycerides and phospholipids were significantly elevated in the high-fat model group, and part of them was reduced after guarana treatment. Western blot found that guarana inhibited the expression of hepatic fatty acid and triglyceride synthesis-related proteins and increased the expression of fatty acid β-oxidation-related proteins. Abnormalities in triglyceride and phospholipid metabolism are the main characteristics of plasma lipid metabolism in obese rats induced by high-fat diet. Guarana may regulate partial triglyceride and phospholipid metabolism by inhibiting hepatic fatty acid and triglyceride synthesis and increasing fatty acid β-oxidation, thereby improving rat obesity and dyslipidemia.

2.
Braz. J. Pharm. Sci. (Online) ; 59: e22106, 2023. tab, graf
Article in English | LILACS | ID: biblio-1439518

ABSTRACT

Abstract Guarana (Paullinia cupana) is a native plant from the Amazon whose seeds contain a high concentration of caffeine. Aqueous extract of guarana is widely used in the world. In this study, the objective was to develop and validate a High-Performance Liquid Chromatography method for the determination of caffeine in extracts and commercial beverages based on guarana. A sensitive, simple, and viable high performance liquid chromatographic method without the need of an analyte extraction procedure was developed and validated according to Brazilian and international requirements. The method presented high performance, fulfilling Brazilian and international requirements, in addition to allowing product compliance tests. Results confirmed high selectivity and linearity (>0.999) between 5 to 135 ug/mL, with no significant matrix effect. Detection and quantification limits were 0.02 µg/mL and 2 µg/mL, respectively. Precision was less than 4 %, and accuracy varied from 99.9-120 %. Applicability of the method was demonstrated by conducting a limited evaluation in products containing caffeine. Commercial extracts showed quite different caffeine levels, while carbonated drinks follow Brazilian and American recommendations. Our results indicate that the developed method can be used to evaluate the quality of the guarana extract and of products containing caffeine


Subject(s)
Seeds/classification , Caffeine/agonists , Plant Extracts/analysis , Chromatography, High Pressure Liquid/methods , Paullinia/adverse effects , Plants/classification , Beverages/classification , Total Quality Management/standards
3.
Braz. J. Pharm. Sci. (Online) ; 59: e22381, 2023. tab, graf
Article in English | LILACS | ID: biblio-1439529

ABSTRACT

Abstract Acai (Euterpe oleracea Mart.) and guarana (Paullinia cupana Kunth) are native species from the Amazon Forest that in folk medicine are used to treat several diseases due to their anti-inflammatory and antioxidant properties. This review brings together findings from different studies on the potential neuroprotective effects of acai and guarana, highlighting the importance of the conservation and sustainable exploitation of the Amazon Forest. A bibliographic survey in the PubMed database retrieved indexed articles written in English that focused on the effects of acai and guarana in in vitro and in vivo models of neurodegenerative diseases. In general, treatment with either acai or guarana decreased neuroinflammation, increased antioxidant responses, ameliorated depression, and protected cells from neurotoxicity mediated by aggregated proteins. The results from these studies suggest that flavonoids, anthocyanins, and carotenoids found in both acai and guarana have therapeutic potential not only for neurodegenerative diseases, but also for depressive disorders. In addition, acai and guarana show beneficial effects in slowing down the physiological aging process. However, toxicity and efficacy studies are still needed to guide the formulation of herbal medicines from acai and guarana.


Subject(s)
Amazonian Ecosystem , Paullinia/adverse effects , Euterpe/adverse effects , Fruit/classification , In Vitro Techniques/methods , Neuroprotective Agents/classification , Neurodegenerative Diseases/pathology , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology
5.
Rev. bras. farmacogn ; 29(1): 77-110, Jan.-Feb. 2019. tab, graf
Article in English | LILACS | ID: biblio-990764

ABSTRACT

Abstract Seeds of guarana (Paullinia cupana Kunth, Sapindaceae) feature diverse pharmacological functions, for example, antimicrobial, antioxidant, anticarcinogenic, stimulating, and cognitive functions, as well as liver protection and weight loss. Many of these actions are probably due to the high content of methylxanthines and tannins in its seeds. In Brazil, the world's largest producer of guarana, the plant material is predominantly used in the soft drinks industry, although it is also used in the cosmetic and pharmaceutical industries. Although the Amazon region has the largest cropping area, the state of Bahia is the main guarana producer in Brazil (71%). This review focuses mainly on the possible pharmacological actions of guarana that have been investigated. Moreover, it discusses less-considered topics, such as the toxicology and quality control of seeds and extractives of guarana that will ultimately influence the safety of its use. In addition, it presents a detailed discussion of the methods used to prepare herbal drugs and their extracts, focusing on the importance of standardization and on the direct impact of preparatory factors, on the pharmacological properties of guarana extracts.

6.
Braz. j. med. biol. res ; 51(9): e7552, 2018. tab, graf
Article in English | LILACS | ID: biblio-951753

ABSTRACT

Guarana (Paullinia cupana) is habitually ingested by people in the Amazon region and is a key ingredient in various energy drinks consumed worldwide. Extension in longevity and low prevalence of chronic age-related diseases have been associated to habitual intake of guarana. Anti-aging potential of guarana was also demonstrated in Caenorhabditis elegans; however, the mechanisms involved in its effects are not clear. Herein, we investigated the putative pathways that regulate the effects of guarana ethanolic extract (GEE) on lifespan using C. elegans. The major known longevity pathways were analyzed through mutant worms and RT-qPCR assay (DAF-2, DAF-16, SKN-1, SIR-2.1, HSF-1). The possible involvement of purinergic signaling was also investigated. This study demonstrated that GEE acts through antioxidant activity, DAF-16, HSF-1, and SKN-1 pathways, and human adenosine receptor ortholog (ADOR-1) to extend lifespan. GEE also downregulated skn-1, daf-16, sir-2.1 and hsp-16.2 in 9-day-old C. elegans, which might reflect less need to activate these protective genes due to direct antioxidant effects. Our results contribute to the comprehension of guarana effects in vivo, which might be helpful to prevent or treat aging-associated disorders, and also suggest purinergic signaling as a plausible therapeutic target for longevity studies.


Subject(s)
Animals , Plant Extracts/pharmacology , Caenorhabditis elegans/drug effects , Paullinia/chemistry , Antioxidants/pharmacology , Time Factors , Aging/drug effects , Caenorhabditis elegans/physiology , Reverse Transcriptase Polymerase Chain Reaction , Longevity/drug effects , Antioxidants/isolation & purification
7.
Neotrop. ichthyol ; 14(1): e150062, 2016. tab, graf
Article in English | LILACS | ID: lil-776486

ABSTRACT

ABSTRACT A new species of Corydoras is described from the rio Araguaia basin, Goiás, Brazil. The new species can be distinguished from its congeners by presenting the following features: infraorbital 1 with very large ventral laminar expansion; infraorbital 2 contacting compound pterotic; flanks densely covered by irregular black spots; and ventral surface of trunk densely covered by coalescent relatively well-developed platelets. It is also discussed the possibility that C. araguaiaensis comprehends a complex of species.


RESUMO Uma espécie nova de Corydoras é descrita da bacia do rio Araguaia, Goiás, Brasil. A espécie nova pode ser distinguida de suas congêneres por apresentar as seguintes características: infraorbital 1 com expansão laminar ventral muito grande; infraorbital 2 em contato com o pterótico composto; flancos densamente cobertos por manchas pretas irregulares e superfície ventral do tronco densamente coberta por plaquetas coalescentes relativamente bem desenvolvidas. Discute-se também a possibilidade de C. araguaiaensis compreender um complexo de espécies.


Subject(s)
Animals , Catfishes/classification
8.
Rev. bras. farmacogn ; 25(3): 292-300, May-June 2015. tab, ilus
Article in English | LILACS | ID: lil-757441

ABSTRACT

AbstractGuaraná (Paullinia cupana Kunth, Sapindaceae) is well known for its dietary and pharmaceutical potential, and the semipurified extract of guaraná shows antidepressant and panicolytic effects. However, the low solubility, bioavailability and stability of the semipurified extract limit its use as a component of pharmaceutical agents. Delivery of the semipurified extract in a microparticle form could help to optimize its stability. In this study, microparticles containing semipurified extract of guaraná were obtained by the spray-drying technique, using a combination of maltodextrin and gum arabic. The raw materials and microparticles produced were characterized by particle size analysis, differential scanning calorimetry, thermogravimetric analysis, and scanning electron microscopy. The drug content and antioxidant capacity were also evaluated. In vitrodissolution tests using flow cell dissolution apparatus, were carried out to investigate the influence of formulation parameters on the release of semipurified extract of guaraná from the microparticles. The spray-drying technique and the processing conditions selected gave satisfactory encapsulation efficiency (80–110%) and product yield (55–60%). The mean diameter of microparticles was around 4.5 µm. The DPPH radical scavenging capacity demonstrated that microparticles can protect the semipurified extract of guaraná from the effect of high temperatures during the process maintained the antioxidant capacity. Differential scanning calorimetry results indicated an interaction between semipurified extract of guaraná and gum arabic: maltodextrin in the microparticles, and thermogravimetric analysis indicate that the profile curves of the microparticles are similar to the adjuvants used in drying, probably due to the higher proportion of adjuvants compared to semipurified extract of guaraná. In vitro dissolution tests demonstrate that all formulations complete dissolution within 60 min. Microencapsulation improved the technological characteristics of the powders and preserved the antioxidant properties. The study demonstrated the feasibility of producing these microparticles for a one-step process using spray drying. The composition of each formulation influenced the physical and chemical characteristics. This spray-drying technique can be used as an efficient and economical approach to produce semipurified extract of guaraná microparticles.

9.
Einstein (Säo Paulo) ; 11(4): 435-438, out.-dez. 2013. graf
Article in Portuguese | LILACS | ID: lil-699852

ABSTRACT

OBJETIVO: Avaliar se a Paullinia cupana diminui o número e a gravidade dos fogachos em mulheres após diagnóstico de câncer de mama. MÉTODOS: Estudo piloto prospectivo fase II realizado com mulheres que sobreviveram ao câncer de mama, que completaram o tratamento pelo menos 3 meses antes e que apresentavam ao menos 14 episódios de fogachos por semana. Utilizando o desenho de Simon para que a primeira etapa fosse considerada positiva, ao menos 9 de 15 mulheres deveriam ter a gravidade dos fogachos diminuída em pelo menos 50%. As pacientes receberam 50mg do extrato seco de Guaraná oralmente 2 vezes por dia por 6 semanas. Foram avaliadas, a gravidade e a frequência dos fogachos. RESULTADOS: Dezoito pacientes iniciaram o tratamento com Paullinia cupana e 15 completaram o estudo. Três pacientes deixaram o estudo imediatamente após iniciarem o tratamento em razão de dificuldade na participação e não adesão. Das 15 pacientes que completaram o estudo, 10 obtiveram diminuição de mais de 50% dos índices de gravidade de fogachos. Durante as 6 semanas de tratamento, diminuições estatisticamente significativas foram observadas tanto no número de fogachos (p=0,0009), quanto nos índices de gravidade (p<0,0001). Paullinia cupana foi bem tolerada, e não houve relato de toxicidade como causa de saída do estudo. CONCLUSÕES: Paullinia cupana pareceu promissora para o controle de fogachos. Estudos mais extensivos são necessários.


OBJECTIVE: To evaluated whether Paullinia cupana decrease number and severity of hot flashes in breast cancer survivors. METHODS: This was a prospective phase II pilot study. We studied female breast cancer survivors who had completed the cancer treatment 3 months previously and who were experiencing at least 14 hot flashes per week. At least 9 of the 15 patients were required to have a decrease of at least 50% in hot flash severity score in keeping with the Simon Design. Patients received 50mg of dry extract of Paullinia cupana orally twice a day for 6 weeks. We assessed both frequency and severity of hot flashes. RESULTS: A total of 18 patients started the Paullinia cupana treatment, and 15 completed the study. Three patients left the study immediately after starting the treatment because of personal difficulties in participation or noncompliance. Of the 15 patients who completed the study 10 had a decrease of more than 50% in hot flash severity scores. During the 6 weeks of treatment, statistically significant decreases were seen in both numbers of hot flashes (p=0.0009) and severity scores (p<0.0001). Paullinia cupana was well tolerated, and there were no instances of discontinuation because of toxicity. CONCLUSIONS: Paullinia cupana appears promising for controlling hot flashes. More extensive studies seem warranted.


Subject(s)
Adult , Aged , Female , Humans , Middle Aged , Breast Neoplasms/complications , Hot Flashes/drug therapy , Hot Flashes/etiology , Paullinia , Phytotherapy , Plant Extracts/therapeutic use , Pilot Projects , Prospective Studies , Severity of Illness Index , Treatment Outcome
10.
Rev. bras. farmacogn ; 23(1): 186-193, Jan.-Feb. 2013. ilus, graf, tab
Article in English | LILACS | ID: lil-666182

ABSTRACT

This study evaluated the technological feasibility of producing a semipurified extract of guaraná (Paullinia cupana Kunth, Sapindaceae) in tablet form, using a direct-compression process. Maltodextrin and gum arabic were used to produce the extract microparticles, in order to protect the microparticles against such factors as temperature, oxidation, and humidity. Using pharmacopoeial methodologies, technological and physicochemistry tests (determination of residual moisture, of bulk and tapped density, Hausner ratio, compressibility and compactibility index, appearance, mean weight, hardness, friability, disintegration time, determination of EPA amount in tablets and in vitro release profile) were conducted. The formulation containing 200 mg of microparticles, 170 mg microcrystalline cellulose, and 10 mg lactose gave the best results in terms of hardness (116 N), friabilility (0.28%), mean weight (0.3821 g), and disintegration time (25 min) for a tablet designed for oral administration. The results met pharmacopoeial specifications, and the tablets are suitable for oral administration.

11.
Braz. j. pharm. sci ; 47(2): 269-277, Apr.-June 2011. ilus, tab
Article in English | LILACS | ID: lil-595815

ABSTRACT

"Guaraná" (Paullinia cupana) is used as a physical activity enhancer and stimulator due to its methylxanthines and condensed tannins. The aim of this work was to evaluate the dissolution behavior of five herbal medicines in the form of capsules and tablets containing guaraná. Assay and dissolution methods were validated and results obtained allowed simultaneous marker quantification with precision, accuracy, selectivity and robustness. Findings showed that 100 percent of the herbal medicinal products analyzed did not provide satisfactory results concerning the presence of four markers, 60 percent had three markers (caffeine, catechin and epicatechin), while 40 percent had only caffeine at tested dosage forms. In addition, after 30 minutes, only capsule A showed at least 80 percent of the dissolved markers. In other capsules, marker dissolution did not exceed 60 percent whereas 60 percent of the samples had some characteristic pharmacotechnical problems. These results evidence the need for rigorous quality control to help ensure the therapeutic action of these drugs. To this end, dissolution studies are an essential tool for quality assurance of herbal medicines.


Guaraná (Paullinia cupana) é utilizado como revigorante e estimulante devido à presença de metilxantinas e taninos condensados. Este trabalho visou avaliar o comportamento de dissolução de cinco fitoterápicos, na forma de cápsulas e comprimidos, contendo guaraná. O método de quantificação e de dissolução foram validados e os resultados obtidos permitiram a quantificação dos marcadores simultaneamente, com precisão, exatidão, seletividade e robustez. Foi verificado que 100 por cento dos fitoterápicos analisados encontravam em desacordo quanto à presença dos quatro marcadores, sendo que 60 por cento apresentaram três marcadores (cafeína, catequina e epicatequina) e 40 por cento apresentaram somente a cafeína. Além disso, após o tempo de 30 minutos de ensaio foi possível observar que somente a cápsula A apresentou pelo menos 80 por cento dos marcadores dissolvidos. Nas demais cápsulas o comportamento de dissolução apresentado pelos marcadores não ultrapassou 60 por cento e, além disso, 60 por cento das amostras apresentaram alguns problemas farmacotécnicos característicos. Frente aos resultados obtidos torna-se evidente a necessidade de um rigoroso controle de qualidade que contribua para assegurar a ação terapêutica desses medicamentos e, nesse sentido, o estudo de dissolução constitui uma ferramenta essencial para a garantia de qualidade dos fitoterápicos.


Subject(s)
Dissolution/analysis , /pharmacology , Phytotherapeutic Drugs , Plants, Medicinal , Evaluation Studies as Topic , Chromatography, Liquid/methods , Pharmacognosy/methods , Quality Control
12.
Rev. Assoc. Med. Bras. (1992) ; 57(2): 211-219, mar.-abr. 2011. ilus
Article in Portuguese | LILACS | ID: lil-584075

ABSTRACT

A fadiga relacionada ao câncer (FRC) é um dos sintomas mais prevalentes em pacientes com câncer, sendo reportada por 50 por cento a 90 por cento dos pacientes durante o curso da doença ou do seu tratamento, impactando na qualidade de vida de forma severa além de diminuir a capacidade funcional diária dos pacientes. Uma abordagem ampla deve ser realizada com orientações gerais sobre fadiga, além da determinação de um plano individualizado de abordagem terapêutica. Pacientes com fadiga moderada ou severa devem se beneficiar de ambas as medidas farmacológicas e não farmacológicas a serem adotadas, enquanto pacientes que apresentem fadiga leve que não interfira na qualidade de vida podem ser tratados com medidas não farmacológicas como única medida terapêutica. O tratamento não farmacológico se mostra promissor com o uso de terapias cognitivas-comportamentais (conservação de energia e organização de atividades diárias realizadas, ECAM), exercícios físicos e talvez terapias do sono. O tratamento farmacológico tem mostrado resultados promissores que incluem o uso de psicoestimulantes tais como metilfenidato e dexmetilfenidato, modanafil (em pacientes com fadiga severa) e agentes estimuladores de eritropoietina em pacientes com anemia associada à quimioterapia e hemoglobina menor que 10 mg/dL. Além dessas drogas, o uso de Guaraná (Paullinia cupana) tem-se mostrado uma opção promissora, com efeitos benéficos no tratamento da fadiga física e mental relacionada ao câncer. Por ser uma opção sem efeitos colaterais significantes e uma planta nacional, torna-se atrativo considerando o fácil acesso a esta medicação por seu baixo custo e fácil adesão ao tratamento. O tratamento pode ser oferecido através de uma abordagem multimodal e multidisciplinar que individualize as opções terapêuticas dentro de um contexto que promova o diagnóstico acurado da FRC, além de um tratamento específico e adequado para cada paciente que apresente este sintoma tão importante e de grande impacto na qualidade de vida de pacientes com câncer.


Cancer-related fatigue is the most prevalent cancer symptom, reported in 50 percent-90 percent of patients and severely impacts quality of life and functional capacity. The condition remains underreported and often goes untreated. Guidelines suggest screening for fatigue at the initial visit, when the diagnosis of advanced disease is made, and at each chemotherapy session, as well as the identification of treatable contributing factors such as anemia, hypothyroidism, depression and sleep disorders. Brief assessment tools such as the Brief Fatigue Inventory or the Visual Analog Scale may be appropriate in the initial scoring of fatigue severity, but the initial approach to treatment usually requires a more comprehensive assessment, education, and the determination of an individualized treatment plan. Patients with moderate or severe fatigue may benefit from both pharmacological and non-pharmacological interventions, whereas mild fatigue that does not interfere with quality of life can be treated with non-pharmacological measures alone. Non-pharmacological measures that have shown to be promising include cognitive-behavioral interventions such as energy conservation and activity management (ECAM), exercise and perhaps sleep therapy. Many other modalities may be beneficial and can be used on an individual basis, but there is insufficient evidence to promote any single treatment. Pharmacological therapies that have shown to be promising include the psycho-stimulants methylphenidate and dexmethylphenidate, modafinil (in severely fatigued patients only), and erythropoietin-stimulating agents in patients with chemotherapy-associated anemia and hemoglobin levels < 10 g/dL. Recently, our group reported impressive results with the use of the dry extract of Guarana (Paullinia cupana), with no significant side effects and at low cost, for the treatment of physical and mental cancer-related fatigue.


Subject(s)
Humans , Fatigue/etiology , Neoplasms/complications , Fatigue/diagnosis , Fatigue/therapy , Neoplasms/diagnosis , Quality of Life
13.
Rev. bras. farmacogn ; 20(6): 866-870, dez. 2010. graf, tab
Article in Portuguese | LILACS | ID: lil-572623

ABSTRACT

As sementes de guaraná (Paullinia cupana Kunth, Sapindaceae) são utilizadas como estimulante e os principais constituintes químicos são as metilxantinas e os taninos, tais como catequina e epicatequina. Este trabalho teve por objetivo investigar um método por cromatografia líquida de alta eficiência (CLAE) para quantificar, simultaneamente, cafeína, teofilina, teobromina, catequina e epicatequina em pó de guaraná. Os valores obtidos foram comparados com os resultados encontrados no método espectrofotométrico da Farmacopéia Brasileira IV ed. Pelo método cromatográfico, os teores de metilxantinas e taninos totais foram de 4,04 por cento e 1,48 por cento, respectivamente. Os teores de metilxantinas e taninos totais, obtidos pelo método espectrofotométrico, foram de 4,88 por cento e 4,05 por cento, respectivamente. Acredita-se que, nas condições experimentais empregadas, o método espectrofotométrico não foi específico, quantificando outras substâncias fenólicas presentes no guaraná. Portanto, sugere-se o emprego desse método cromatográfico no controle de qualidade do guaraná em pó, por ser preciso, sensível, específico e rápido.


The seeds of Paullinia cupana Kunth, Sapindaceae, are used as a stimulant and the main chemical constituents are the methylxanthines and tannins, as catechin and epicatechin. This study aimed to investigate a method by high performance liquid chromatography (HPLC) to quantify both caffeine, theophylline, theobromine, catechin and epicatechin in powdered of P. cupana. The values obtained were compared with the results of the spectrophotometric method of the Brazilian Pharmacopoeia IV ed. For the chromatographic method, the levels of methylxanthines and total tannins were 4.04 percent and 1.48 percent, respectively. The levels of methylxanthines and total tannins obtained by the spectrophotometric method, were 4.88 percent and 4.05 percent, respectively. It is believed that, under our experimental conditions, the spectrophotometric method was not specific and quantified others phenolic substances present in the P. cupana. Therefore we suggest the use of this chromatographic method in quality control of P. cupana powder, to be accurate, sensitive, specific and fast.

14.
Ciênc. agrotec., (Impr.) ; 33(spe): 2005-2010, 2009. ilus, tab
Article in Portuguese | LILACS | ID: lil-542358

ABSTRACT

Apesar da importância econômica do guaranazeiro (Paullinia cupana H.B.K. var. sorbilis (Mart.) Ducke) em algumas regiões do Brasil, existem poucas informações sobre sua caracterização fenológica. Assim, realizou-se um estudo cujo objetivo foi de quantificar a produção de fitomassa e sua distribuição, em uma população de guaranazeiros, originadas de propagação sexuada. Foram avaliadas cinco plantas adultas, que lançaram mais de 100 ramos por planta ano-1, dos quais apenas 50 por cento produziram frutos. As plantas lançaram entre 445 e 1294 inflorescências por ano, porém, de 67 por cento a 98 por cento produziram apenas um fruto. A produção de matéria seca total foi estimada em 15,8 kg por planta ao ano, o que corresponde 6350 kg ha ano-1. Nas plantas, o maior acúmulo de matéria seca apresentou a seguinte ordem: folhas>ramos>sementes>ráquis>casca dos frutos+arilo> pecíolos.


The commerce of guarana seeds (Paullinia cupana H.B.K. var. sorbilis (Mart.) Ducke) is economically important in some regions of Brazil. However, few studies are found about its phenological characteristics. The aim of this paper was to study the production and distribution of organic matter in adult plants of guarana. Five individuals, which had more than 100 branches per plant/year, were evaluated. One found out that only 50 percent of the branches had fruits. The guarana plants had between 445 and 1294 inflorescences but of these, 67 percent to 98 percent had only one fruit. The total organic matter was evaluated in 15.8 kg per plant year-1 which means around 6350 kg ha year-1. The organic matter storage in guarana plant had the following sequence: leaves>branches>seeds>rachis> fruit peel+aril> petiole.

15.
Braz. j. med. biol. res ; 41(4): 305-310, Apr. 2008. ilus, tab
Article in English | LILACS | ID: lil-479684

ABSTRACT

We showed that guaraná (Paullinia cupana Mart var. sorbilis) had a chemopreventive effect on mouse hepatocarcinogenesis and reduced diethylnitrosamine-induced DNA damage. In the present experiment, we evaluated the effects of guaraná in an experimental metastasis model. Cultured B16/F10 melanoma cells (5 x 10(5) cells/animal) were injected into the tail vein of mice on the 7th day of guaraná treatment (2.0 mg P. cupana/g body weight, per gavage) and the animals were treated with guaraná daily up to 14 days until euthanasia (total treatment time: 21 days). Lung sections were obtained for morphometric analysis, apoptotic bodies were counted to calculate the apoptotic index and proliferating cell nuclear antigen-positive cells were counted to determine the proliferation index. Guaraná-treated (GUA) animals presented a 68.6 percent reduction in tumor burden area compared to control (CO) animals which were not treated with guaraná (CO: 0.84 ± 0.26, N = 6; GUA: 0.27 ± 0.24, N = 6; P = 0.0043), a 57.9 percent reduction in tumor proliferation index (CO: 23.75 ± 20.54, N = 6; GUA: 9.99 ± 3.93, N = 6; P = 0.026) and a 4.85-fold increase in apoptotic index (CO: 66.95 ± 22.95, N = 6; GUA: 324.37 ± 266.74 AB/mm², N = 6; P = 0.0152). In this mouse model, guaraná treatment decreased proliferation and increased apoptosis of tumor cells, consequently reducing the tumor burden area. We are currently investigating the molecular pathways of the effects of guaraná in cultured melanoma cells, regarding principally the cell cycle inhibitors and cyclins.


Subject(s)
Animals , Female , Mice , Antineoplastic Agents, Phytogenic/therapeutic use , Cell Proliferation/drug effects , Lung Neoplasms/prevention & control , Melanoma, Experimental/prevention & control , Paullinia/chemistry , Plant Extracts/therapeutic use , Lung Neoplasms/secondary , Mice, Inbred BALB C , Melanoma, Experimental/secondary , Proliferating Cell Nuclear Antigen/analysis
16.
Rev. bras. farmacogn ; 14(1): 15-20, 2004. graf, tab
Article in Portuguese | LILACS | ID: lil-570838

ABSTRACT

Amostras de sementes de guaraná provenientes da região amazônica e secas por diferentes métodos, foram analisadas por técnicas farmacopéicas e outras, e o extrato liofilizado foi analisado por cromatografia líquida de alta eficiência (CLAE). Realizou-se o doseamento de metilxantinas (MX) e dos taninos totais (TT), através de métodos espectrofotométricos, para a comparação das amostras. O maior teor de MX foi obtido com as sementes secas em tacho metálico por 4 h com adição de água, enquanto que o maior teor de TI foi obtido com a amostra torrada em tacho metálico por 4 h sem água. A análise cromatográfica por CLAE apresentou tempos de retenção para catequina, epicatequina e cafeína de 6,17; 8,85 e 11,91 min, respectivamente.


Contrai quality of the vegetable drug "guaraná", with samples of seeds obtained from Amazonian area, were carried out by pharmacopoeial assays, and the extract were analysed by HPLC. The determination of methylxantines (MX) and total tannins (TI) was performed by spectrophotometric methods. The most yield of MX were showed by the sample GTIB and for TI the best result were obtained by the sample GTIM4s. The analysis by HPLC showed retention times for catechin, epicatechin and cafteine of 6.17,8.85 and 11.91 min, respectively.

17.
Rev. Inst. Adolfo Lutz ; 47(1/2): e36890, dez. 1987. ilus
Article in Portuguese | LILACS, ColecionaSUS, SES-SP, CONASS, SESSP-IALPROD, SES-SP, SESSP-IALACERVO | ID: lil-66589

ABSTRACT

Foram comparados os resultados da determinação quantitativa da cafeína em guaraná de acordo com o método gravimétrico descrito na Farmacopeia Brasileira, 3a. edição, com os da determinação espectrofotométrica dos resíduos obtidos dissolvidos em ácido clorídrico 0,1 N, com leitura a 273nm. A presença de outras substâncias de natureza não xantílica no resíduo foi mostrada através de cromatografia em camada delgada, usando-se fases móveis de diferentes polaridades. Os valores obtidos por espectrofotometria foram sempre menores do que os obtidos por gravimetria (AU).


Subject(s)
Spectrophotometry , Caffeine , Carbonated Beverages
SELECTION OF CITATIONS
SEARCH DETAIL